Last quarter (Q4 2023), Emergent Biosolutions's total revenue was $275.80M, a decrease of -175.19% from the same quarter last year. In Q4, Emergent Biosolutions's net income was $-52.80M. See Emergent Biosolutions’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 1.04B	$ 1.05B	$ 1.12B	$ 334.90M	$ 1.56B	$ 1.11B
Cost of Revenue	$ 705.40M	$ 705.40M	$ 693.70M	$ -382.00M	$ 524.00M	$ 433.50M
Gross Profit	$ 339.40M	$ 343.90M	$ 427.20M	$ 735.50M	$ 1.03B	$ 672.50M
Operating Expense	$ 1.12B	$ 1.78B	$ 1.29B	$ -1.44B	$ 597.60M	$ 558.40M
Operating Income	$ -424.20M	$ -726.40M	$ -172.70M	$ 94.60M	$ 433.80M	$ 114.10M
Net Non Operating Interest Income Expense	$ -87.90M	$ -87.90M	$ -37.30M	$ -34.50M	$ -31.30M	$ -38.40M
Other Income Expense	$ 217.90M	$ 217.90M	$ 6.80M	$ -296.00M	$ 4.70M	$ 1.70M
Pretax Income	$ -731.20M	$ -731.20M	$ -221.70M	$ 314.40M	$ 407.20M	$ 77.40M
Tax Provision	$ 29.30M	$ 29.30M	$ 2.10M	$ 83.50M	$ 102.10M	$ 22.90M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -760.50M	$ -760.50M	$ -223.80M	$ 230.90M	$ 305.10M	$ 54.50M
Basic EPS	$ -14.89	$ -14.85	$ -4.47	$ 4.32	$ 5.79	$ 1.06
Diluted EPS	$ -14.89	$ -14.85	$ -4.47	$ 4.27	$ 5.67	$ 1.04
Basic Average Shares	$ 204.80M	$ 51.20M	$ 50.10M	$ 53.50M	$ 52.70M	$ 51.50M
Diluted Average Shares	$ 204.80M	$ 51.20M	$ 50.10M	$ 54.10M	$ 53.80M	$ 52.40M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	$ 7.88	$ 2.91
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 1.83B	$ 2.48B	$ 1.99B	$ -1.82B	$ 1.12B	$ 991.90M
Net Income From Continuing And Discontinued Operation	$ -760.50M	$ -760.50M	$ -223.80M	$ 230.90M	$ 305.10M	$ 54.50M
Normalized Income	$ -42.56M	$ -97.45M	$ -165.84M	-	$ 305.10M	$ 54.50M
Interest Expense	-	-	-	-	$ 31.30M	$ 38.40M
EBIT	$ -643.30M	$ -643.30M	$ -184.40M	$ 348.90M	$ 438.50M	$ 115.80M
EBITDA	$ -496.90M	$ -496.90M	$ -37.00M	$ 476.80M	$ 553.00M	$ 226.50M

Currency in USD

Emergent Biosolutions Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing